← Open Payments lookup

MARCY GOLDBERG: Open Payments

NPI 1295848968 · FRENCH CAMP, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,384 in 28 payments from 12 companies in 2025. Trend: 2023 $520 · 2024 $447 · 2025 $1,384

Long term medical supply or device loan: $997Food & beverage: $387
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation16$1,083
Takeda Pharmaceuticals U.S.A., Inc.2$60
Janssen Biotech, Inc.1$42
Boehringer Ingelheim Pharmaceuticals, Inc.1$34
Regeneron Healthcare Solutions, Inc.1$29
ABBVIE INC.1$27
Celgene Corporation1$21
Genentech USA, Inc.1$20
Fennec Pharmaceuticals, Inc.1$19
Merck Sharp & Dohme LLC1$18

Products named: KISQALI, FRUZAQLA, RYBREVANT, SCEMBLIX, OPDIVO, LIBTAYO, EPKINLY, Fabhalta.

Industry payments across CA — which companies pay providers there.